Abstract:Nonalcoholic Liver Disease (NAFLD) is increasing in frequency in daily practice. Evaluation of such patients needs to assess steatosis, fibrosis and inflammation.A new Ultrasound(US) system from Canon noninvasively evaluates these parameters by measuring shear waves speed (2D-SWE) - related to viscoelasticity and fibrosis; dispersion (DI) - related to viscosity and inflammation, and attenuation parameter (ATI) - related to steatosis. Aim: To evaluate the usefulness of 2D-SWE, DI and ATI measurements obtained using Aplio i800 from Canon, for the noninvasive assessment of liver fibrosis, inflammation, and steatosis using Transient Elastography (TE) with Controlled Attenuation Parameter (CAP) as the reference method. Material and Method: 113 consecutive subjects were included in the study group, mostly NAFLD patients, in whom liver stiffness (LS) and steatosis were evaluated in the same session by means of 2 elastography techniques: TE with CAP (FibroScan, EchoSens) and 2D-SWE with ATI(Aplio I800, Canon). Reliable LS measurements were defined for TE as the median value of 10 measurements with an interquartile range/median ratio (IQR/M) < 30% and for 2D-SWE the median value of 5 measurements performed in a homogeneous area of liver parenchyma, with an IQR/M < 30%. Dispersion was also assessed with the Aplio system. To discriminate between TE fibrosis stages we used the following cut-offs [1]: F ≥ 2: 8.4 kPa and F4: 13.2 kPa and to discriminate between steatosis stages we used the following cut-offs recommended by the manufacturer: S1(mild) – 230db/m, S2(moderate) - 275db/m, S3(severe) - 300db/m. Results: Reliable LS measurements were obtained in 99.1% subjects by both 2D-SWE and TE.A very strong positive correlation was found between the LS values obtained by the 2 Methods: r = 0.88, p < 0.0001 and between the attenuation coefficients of steatosis obtained by the 2 methods, r = 0.81, p < 0.0001. The best cut-off value for fibrosis, for F0/1 was ≤ 6.2 kPa (AUROC 0.82; Se = 75%; Sp = 85.5%), for F ≥ 2 it was 7.9 kPa (AUROC 0.96; Se = 90.4%; Sp = 95.6%), for F4 it was 11.7 kPa (AUROC 0.99; Se = 100%; Sp = 96%). Regarding steatosis, the best cut-off values were: for S1 = 0.64 dB/cm/mHz (AUROC 0.89; Se = 73.6%; Sp = 88.8%), for S2 = 0.79 dB/cm/mHz (AUROC 0.88; Se = 63.4%; Sp = 96.4%), for S3 = 0.86dB/cm/mHz (AUROC 0.95; Se = 45%; Sp = 100%). When we divided the cohort into healthy vs patients with chronic hepatopathies, we found out that the mean DI values in the pathology group were higher than in the healthy group(12.4 ± 2.7 vs 11.5 ± 1.9, p = 0.03) Conclusion: 2D-SWE and ATI measurements with the new system strongly correlate with TE and CAP results 110.1111/apt.14529

Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease

Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis

Endoscopic Ultrasound-based Shear Wave Elastography for Detection of Advanced Liver Disease

Between-Visit Reproducibility of Shear Wave Viscoelastography in Volunteers and Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Prospective evaluation of liver shearwave elastography measurements with 3 different technologies and same day liver biopsy in patients with chronic liver disease

Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study

Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study

Value of viscosity, viscoelasticity and attenuation measurement using shear wave ultrasound elastography

Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD

Comparison of Transient Elastography and Point Shear Wave Elastography for Analysis of Liver Stiffness: A Prospective Study

Comparison of the diagnostic accuracy of shear wave elastography with transient elastography in adult nonalcoholic fatty liver disease: a systematic review and network meta-analysis of diagnostic test accuracy

Understanding confounding factors allows for accurate interpretation of liver stiffness measurements by ElastQ, a novel 2D shear wave elastography technique

Assessment of liver fibrosis using 2-dimensional shear wave elastography: a prospective study of intra- and inter-observer repeatability and comparison with point shear wave elastography

Diagnostic efficiency on ultrasound shear wave elastography in evaluation of steatosis severity for non-alcoholic fatty liver disease: a rat model

Shear wave elastography with a new reliability indicator.

Study of detection times for liver stiffness evaluation by shear wave elastography

Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography

Accuracy of transient elastography in assessing fibrosis at diagnosis in individuals with autoimmune liver disease.

Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium

How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A Review of the Literature and Proposed Multistep Approach

Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease